Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson's ortho-clinical testing business for $4.15 billion, according to a Mass Device report. The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.
More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement
Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B
Spinal TechCopyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.